Son, Yeeun https://orcid.org/0000-0003-3324-7635
Kenny, Timothy C. https://orcid.org/0000-0001-8258-5716
Khan, Artem https://orcid.org/0000-0002-1240-8674
Birsoy, Kıvanç https://orcid.org/0000-0002-7579-9895
Hite, Richard K. https://orcid.org/0000-0003-0496-0669
Article History
Received: 28 September 2023
Accepted: 2 April 2024
First Online: 1 May 2024
Competing interests
: R.K.H. is a consultant for F. Hoffmann-La Roche. K.B. is a scientific adviser to Nanocare Pharmaceuticals and Atavistik Bio. The other authors declare no competing interests.